alphaviru
caus
chronic
incapacit
arthralgia
human
although
patient
cohort
studi
shown
product
chikv
specif
antibodi
fine
specif
antibodi
respons
chikv
complet
defin
macaqu
model
chikv
infect
establish
due
limit
clinic
specimen
importantli
close
relat
human
allow
studi
chronic
infect
identifi
import
chikv
target
studi
serum
sampl
chikvinfect
macaqu
collect
differ
timepoint
post
infect
use
character
antibodi
product
pattern
kinet
result
reveal
antichikv
antibodi
neutral
glycoprotein
capsid
protein
target
antichikv
antibodi
respons
macaqu
furthermor
linear
bcell
epitop
recogn
antichikv
antibodi
identifi
map
structur
local
character
specif
antichikv
antibodi
respons
macaqu
demonstr
import
differ
region
chikvencod
protein
adapt
immun
respons
inform
studi
provid
critic
knowledg
aid
understand
chikv
infect
immun
vaccin
design
preclin
efficaci
studi
chikungunya
viru
chikv
first
describ
epidem
tanzania
east
africa
caus
agent
chikungunya
fever
chikf
chikv
belong
genu
alphaviru
famili
togavirida
envelop
viru
singlestrand
positivesens
rna
genom
rna
genom
cap
end
polyadenyl
end
consist
two
open
read
frame
code
four
nonstructur
protein
three
major
structur
protein
capsid
two
small
cleavag
product
glycoprotein
form
heterodim
associ
trimer
spike
virion
surfac
demonstr
act
helper
protein
bud
matur
process
virion
envelop
last
decad
multipl
chikf
epidem
occur
east
africa
indian
ocean
island
mani
part
south
east
asia
recent
new
episod
chikf
report
america
broaden
geograph
spread
diseas
aed
speci
mosquito
major
arthropod
vector
associ
chikv
transmiss
human
chikv
infect
usual
lead
develop
chikf
character
abrupt
onset
fever
headach
fatigu
nausea
vomit
rash
myalgia
sever
arthralgia
similar
arthralgiacaus
arboviru
infect
fraction
patient
develop
chronic
symptom
last
sever
week
month
current
licens
vaccin
antivir
drug
chikv
infect
human
use
therapi
chikv
infect
often
limit
support
care
despit
develop
sever
anim
model
met
requir
use
preclin
studi
assess
potenti
therapeut
recent
epidemiolog
data
show
increas
import
antibodymedi
protect
chikv
highlight
feasibl
use
antichikv
antibodi
therapeut
prophylact
treatment
howev
inform
exact
target
adapt
immun
respons
either
human
anim
model
remain
limit
although
bcell
epitop
identifi
within
glycoprotein
due
close
lineag
relationship
human
macaqu
macaqu
model
chikv
infect
develop
model
allow
comparison
adapt
immun
human
macaqu
furthermor
inform
obtain
macaqu
studi
valuabl
design
futur
therapeut
studi
aim
investig
kinet
specif
antichikv
antibodi
induc
experiment
infect
cynomolgu
macaqu
macaca
fasciculari
addit
glycoprotein
respons
also
identifi
new
linear
bcell
epitop
recogn
antichikv
antibodi
chikvinfect
macaqu
epitop
potenti
use
futur
develop
vaccin
candid
anim
handl
strict
accord
good
anim
practic
defin
european
direct
accord
recommend
weatheral
report
four
sixyearold
cynomolgu
macaqu
macaca
fasciculari
import
intern
accredit
breed
facil
mauritiu
neg
siv
stlv
herp
b
viru
filovirus
measl
dengu
viru
chikv
hous
facil
permit
number
accord
offic
laboratori
anim
welfar
olaw
usa
standard
cea
accord
french
nation
regul
number
anim
use
number
macaqu
breed
anim
fed
daili
monitor
close
caretak
report
directli
veterinarian
charg
anim
facil
studi
review
approv
region
anim
care
use
committe
accord
european
direct
region
pour
animal
iledefr
sud
fontenay
aux
rose
decis
cell
line
origin
purchas
american
tissu
cultur
collect
atcc
human
embryon
kidney
hek
atcc
babi
hamster
kidney
atcc
cell
adher
recommend
ethic
approv
standard
hek
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
gibco
invitrogen
chikv
isol
imt
use
studi
origin
isol
two
french
patient
return
reunion
island
chikf
outbreak
singaporean
admit
nation
univers
hospit
respect
chikv
clone
rescu
correspond
infecti
cdna
clone
previous
describ
viru
stock
imt
use
vitro
studi
prepar
via
numer
passag
cultur
titer
wash
preclear
centrifug
storag
isol
patient
serum
marseil
passag
three
time
cultur
viru
stock
produc
follow
singl
passag
cell
experiment
infect
macaqu
anim
first
sedat
ketamin
chlorhydr
mgkg
inocul
pfu
chikv
via
saphen
vein
clinic
examin
carri
describ
previous
temperatur
weight
macaqu
record
minut
sedat
sera
collect
bleed
femor
vein
first
chikv
inocul
daili
basi
infect
day
postinfect
dpi
chikvinfect
macaqu
kept
maximum
dpi
neutral
activ
antibodi
chikvinfect
macaqu
sampl
test
triplic
analyz
immunofluorescencebas
cell
infect
assay
hek
cell
amount
chikv
virion
correspond
moi
mix
heatinactiv
macaqu
serum
dilut
incub
hour
gentl
agit
thermomix
virusantibodi
mixtur
ad
hek
cell
seed
plate
incub
hour
medium
remov
cell
replenish
dmem
medium
suppli
fb
incub
hour
fixat
paraformaldehyd
follow
immunofluoresc
quantif
use
cellom
arrayscan
v
percentag
infect
calcul
accord
equat
infect
respond
seroneutr
group
respond
viru
infect
group
protein
chikv
virion
detect
use
modifi
techniqu
previous
describ
reduc
sampl
prepar
sampl
contain
imt
virion
boil
minut
laemmli
buffer
supplement
sd
mm
dtt
nonreduc
sampl
prepar
laemmli
buffer
supplement
sd
without
dtt
boil
sd
migrat
buffer
use
electrophoresi
protein
chikv
virion
separ
sdspage
respect
transfer
nitrocellulos
membran
min
transfer
buffer
mm
tri
mm
glycin
methanol
use
semidri
transfer
method
membran
block
overnight
block
buffer
tbst
supplement
dri
milk
fb
follow
hour
incub
room
temperatur
either
antigenspecif
rabbit
serum
macaqu
serum
sampl
dilut
block
buffer
antigenspecif
sera
capsid
protein
rais
rabbit
passiv
immun
appropri
hrpconjug
antirabbit
igg
antimonkey
igg
secondari
antibodi
ad
incub
hour
follow
chemiluminesc
detect
use
ecl
plu
detect
reagent
amersham
bioscienc
blot
expos
film
pierc
thermo
scientif
develop
polystyren
microtit
plate
maxisorp
nunc
coat
purifi
chikv
infecti
virion
per
ml
pb
ml
per
well
well
block
pb
contain
nonfat
milk
pbstmilk
plate
incub
hour
serum
sampl
dilut
pbstmilk
incub
hour
hrpconjug
rabbit
antimonkey
igg
alpha
diagnost
antibodi
use
detect
macaqu
antibodi
bound
virusco
well
respect
reaction
develop
use
tmb
substrat
sigmaaldrich
termin
stop
reagent
sigmaaldrich
absorb
measur
nm
noninfect
macaqu
serum
use
neg
control
elisa
read
done
duplic
valu
plot
mean
standard
error
mean
sem
biotinyl
peptid
librari
consist
overlap
peptid
mimotop
gener
sequenc
align
differ
chikv
amino
acid
sequenc
previous
describ
peptid
dissolv
dimethyl
sulphoxid
dmso
obtain
stock
concentr
approxim
mgml
peptid
screen
triplic
briefli
streptavidinco
plate
pierc
first
block
sodium
casein
sigmaaldrich
dilut
pbst
pb
coat
peptid
dilut
pbst
incub
room
temperatur
hour
rotat
platform
plate
rins
pbst
incub
chikvinfect
macaqu
serum
sampl
dilut
pbst
hour
plate
rins
follow
incub
respect
antimonkey
igg
antibodi
conjug
hrp
dilut
block
buffer
hour
room
temperatur
detect
peptid
bound
antibodi
reaction
detect
tmb
substrat
solut
sigmaaldrich
termin
sulphur
acid
sigmaaldrich
absorb
read
nm
micropl
autoread
tecan
peptid
consid
posit
absorb
valu
higher
mean
standard
deviat
sd
valu
noninfect
macaqu
serum
control
data
present
mean
sem
structur
data
glycoprotein
retriev
pdb
id
visual
use
ucsf
chimera
softwar
solvent
exclud
molecular
surfac
gener
help
msm
packag
structur
capsid
sequenc
predict
separ
use
individu
itass
queri
visual
use
ucsf
chimera
softwar
data
present
mean
sem
sd
differ
respons
among
group
variou
time
point
group
control
analyz
use
appropri
test
mannwhitney
u
test
twosid
p
valu
less
consid
statist
signific
order
character
chikv
antibodi
respons
obtain
serum
sampl
taken
two
postinfect
timepoint
chikv
infect
macaqu
total
igg
present
serum
quantifi
virionbas
elisa
assay
use
chikv
isol
la
reunion
imt
high
level
chikvspecif
igg
antibodi
respons
detect
dpi
figur
confirm
previou
observ
even
though
igg
level
decreas
time
still
detect
dpi
figur
determin
antichikv
antibodi
neutral
vitro
infect
hek
cell
differ
chikv
isol
imt
carri
presenc
sera
chikvinfect
macaqu
figur
serum
sampl
chikvinfect
macaqu
contain
antibodi
display
neutral
activ
assess
seroneutr
assay
highest
neutral
effici
sampl
taken
dpi
figur
interestingli
stronger
neutral
activ
imt
observ
compar
sampl
dpi
dilut
figur
unexpect
macaqu
experiment
infect
isol
close
relat
imt
isol
presenc
neutral
antibodi
sera
chikvinfect
macaqu
sustain
till
dpi
although
less
effici
sera
dpi
figur
better
defin
antigen
recognit
profil
antibodi
chikvinfect
macaqu
use
chikvinfect
cell
lysat
determin
chikv
antigen
recogn
macaqu
antibodi
figur
none
nonstructur
protein
nsp
recogn
antibodi
serum
sampl
taken
dpi
figur
serum
contain
antibodi
glycoprotein
capsid
protein
figur
anticapsid
antibodi
persist
till
dpi
addit
chikv
virion
purifi
supernat
cell
infect
chikv
isol
reunion
island
imt
singapor
protein
extract
prepar
reduc
nonreduc
condit
describ
assess
immunoblot
assay
use
serum
sampl
chikvinfect
macaqu
figur
first
screen
reveal
serum
sampl
contain
antibodi
recogn
multipl
protein
two
isol
chikv
stronger
reactiv
protein
prepar
nonreduc
condit
compar
protein
prepar
reduc
condit
indic
serum
sampl
contain
antibodi
recogn
linear
disulfid
bond
depend
conform
epitop
figur
similar
reactiv
observ
two
close
relat
chikv
isol
imt
amino
acid
sequenc
similar
suggest
two
isol
present
epitop
common
similar
part
recogn
fraction
figur
antibodi
profil
sera
chikvinfect
macaqu
virusspecif
igg
igm
antibodi
titer
serum
sampl
dilut
determin
elisa
use
purifi
chik
virion
serum
sampl
chikvinfect
macaqu
n
collect
dpi
subject
virionbas
elisa
use
plate
precoat
purifi
chikv
imt
virion
sera
noninfect
macaqu
use
neg
control
data
present
mean
sd
repres
independ
experi
similar
result
b
visual
chikv
immunofluoresc
chikvinfect
cultur
seroneutr
viru
sampl
preincub
heatinactiv
sera
chikvinfect
macaqu
collect
dpi
ad
hek
cell
infect
without
preincub
sera
sera
use
control
analysi
perform
hour
postinfect
hpi
scale
bar
white
mm
repres
microscop
imag
treatment
condit
macaqu
sera
dilut
shown
c
vitro
neutral
activ
sera
chikvinfect
macaqu
sampl
healthi
macaqu
sera
dpi
test
imt
virus
triplic
dilut
healthi
macaqu
sera
chikvinfect
macaqu
sera
result
repres
independ
experi
present
mean
sd
express
percentag
control
infect
mannwhitney
u
test
antibodi
macaqu
infect
third
close
relat
isol
chikv
elisa
assay
perform
use
biotinyl
peptid
librari
mimotop
minim
nonspecif
bind
librari
consist
overlap
peptid
cover
whole
chikv
proteom
pool
peptid
screen
pool
serum
sampl
taken
two
differ
timepoint
sever
peptid
pool
identifi
contain
linear
chikv
bcell
epitop
recogn
serum
antibodi
figur
peptid
pool
posit
bound
serum
antibodi
mark
result
show
two
peptid
pool
capsid
protein
figur
five
glycoprotein
figur
one
protein
figur
three
protein
figur
one
protein
figur
recognit
pattern
antibodi
two
differ
timepoint
ident
peptid
pool
contain
linear
bcell
epitop
detect
remain
protein
data
shown
studi
kinet
establish
adapt
immun
chikvinfect
macaqu
serum
sampl
macaqu
infect
intraven
reunion
island
strain
figur
antichikv
antibodi
demonstr
polymorph
epitop
recognit
differ
chikv
isol
schemat
represent
code
region
chikv
genom
b
total
cell
lysat
prepar
chikvinfect
cell
mockinfect
cell
lysat
subject
sdspage
gel
electrophoresi
left
lane
mockinfect
lysat
right
lane
chikvinfect
lysat
probe
sera
chikvinfect
macaqu
dilut
follow
hrpconjug
antimonkey
igg
secondari
antibodi
arrow
top
panel
indic
chikv
antigen
capsid
detect
antibodi
sera
chikvinfect
macaqu
arrow
middl
panel
nonstructur
protein
lower
panel
structur
protein
indic
chikv
protein
detect
correspond
chikv
antigenspecif
rabbit
sera
perform
dilut
follow
hrpconjug
antirabbit
igg
secondari
antibodi
housekeep
protein
gapdh
probe
specif
antigapdh
antibodi
biolegend
indic
load
control
size
molecular
weight
marker
indic
left
part
diagram
c
purifi
chikv
virion
imt
prepar
reduc
mindtt
nonreduc
condit
subject
sdspage
gel
electrophoresi
probe
sera
chikvinfect
macaqu
dilut
follow
secondari
hrpconjug
antimonkey
igg
size
molecular
weight
marker
indic
left
part
diagram
nonannot
arrow
repres
presenc
disulfid
bond
depend
conform
epitop
recogn
antibodi
sera
chikvinfect
macaqu
figur
map
chikv
bcell
epitop
within
chikv
proteom
sera
chikvinfect
macaqu
dpi
dilut
subject
peptidebas
elisa
peptid
librari
cover
chikv
proteom
use
pool
peptid
name
etc
structur
capsid
b
nonstructur
c
e
protein
sera
noninfect
macaqu
use
neg
control
pool
peptid
consid
contain
posit
linear
bcell
epitop
od
valu
obtain
sera
chikvinfect
macaqu
mean
sd
od
valu
obtain
sera
noninfect
macaqu
data
present
od
valu
obtain
use
sera
infect
macaqu
minu
od
valu
obtain
use
sera
noninfect
macaqu
correspond
pool
peptid
data
repres
averag
two
independ
experi
mean
sd
collect
period
antichikv
antibodi
profil
follow
longitudin
differ
postinfect
phase
figur
macaqu
present
fever
rash
lymphopenia
exhibit
sign
inflamm
indic
cytokin
pattern
biochemistri
assay
dpi
dpi
time
point
acut
phase
earliest
time
point
specif
antichikv
antibodi
detect
figur
dpi
total
signal
came
igm
longer
detect
dpi
earli
convalesc
phase
furthermor
dpi
first
detect
level
igg
also
observ
importantli
later
timepoint
dpi
recoveri
phase
allow
plateau
persist
igg
specif
respons
assess
level
igm
longer
detect
data
shown
next
defin
locat
linear
bcell
epitop
complet
set
singl
peptid
antibodybind
peptid
pool
identifi
figur
screen
serum
sampl
posit
epitop
sequenc
within
nonstructur
structur
protein
illustr
schemat
diagram
figur
two
recogn
region
capsid
protein
locat
nand
cterminu
protein
epitop
glycoprotein
distribut
along
entir
protein
hand
antibodi
macaqu
serum
sampl
fail
recogn
region
protein
glycoprotein
comparison
reactiv
two
timepoint
show
antibodi
recogn
linear
epitop
capsid
immunodomin
region
concert
manner
figur
taken
togeth
result
peptidebas
elisa
assay
consist
immunoblot
assay
confirm
recogn
region
glycoprotein
capsid
protein
epitopecontain
sequenc
map
onto
avail
threedimension
crystal
structur
glycoprotein
pdb
number
predict
structur
capsid
protein
describ
previous
figur
one
epitopecontain
region
capsid
protein
amino
acid
locat
surfac
protein
conceal
fold
protein
figur
furthermor
two
recogn
region
protein
locat
surfac
protein
figur
similar
analyz
glycoprotein
reveal
one
four
recogn
region
map
onto
surfac
protein
figur
major
epitop
cluster
middl
protein
embed
glycoprotein
defin
ideal
anim
model
chikv
studi
remain
constant
challeng
order
understand
immunolog
pathophysiolog
chikv
infect
anim
model
diseas
present
close
similar
human
prefer
order
studi
tempor
pattern
chikv
bcell
epitop
detail
experiment
infect
perform
macaqu
serum
sampl
collect
month
linear
determin
target
sinc
easili
identifi
mediumthroughput
approach
although
conform
epitop
could
also
contribut
antichikv
antibodi
respons
determin
explor
due
limit
detect
linear
peptid
screen
describ
result
show
two
structur
protein
capsid
protein
glycoprotein
three
nonstructur
protein
protein
contain
linear
epitop
recogn
macaqu
antichikv
antibodi
experiment
infect
macaqu
induc
antibodi
structur
protein
also
sever
nonstructur
protein
import
role
antibodi
structur
protein
previous
demonstr
seroneutr
protect
assay
whether
antibodi
target
nonstructur
protein
also
offer
protect
chikv
infect
requir
investig
studi
antibodi
respons
variou
chikv
protein
use
plasma
patient
obtain
differ
postinfect
timepoint
shown
ntermin
region
glycoprotein
provid
longlast
antichikv
antibodi
respons
whole
cours
diseas
specif
high
level
antibodi
chikvinfect
patient
target
linear
bcell
epitop
call
acut
phase
chikv
infect
one
major
bcell
linear
epitop
recogn
antibodi
sera
chikvinfect
macaqu
earli
phase
diseas
amino
acid
tabl
verifi
presenc
antibodi
common
marker
earli
chikv
infect
human
macaqu
previou
find
glycoprotein
capsid
protein
specif
detect
convalesc
recoveri
phase
human
diseas
suggest
pattern
bcell
epitop
recognit
antichikv
antibodi
alter
diseas
progress
acidsensit
region
asr
glycoprotein
suggest
play
role
regul
chikv
particl
gener
virul
vivo
moreov
function
role
asr
regul
glycoprotein
conform
chang
suggest
asr
could
target
neutral
antibodi
previou
result
show
natur
chikv
infect
induc
antibodi
one
asr
epitop
amino
acid
tabl
antibodi
detect
recoveri
phase
month
post
ill
onset
howev
antichikv
antibodi
two
asr
epitop
amino
acid
tabl
detect
sera
experiment
infect
macaqu
furthermor
two
asr
epitop
immunodomin
earli
convalesc
recoveri
phase
contrari
immunodomin
epitop
observ
natur
human
chikv
infect
observ
one
asr
epitop
amino
acid
import
natur
human
infect
experiment
macaqu
infect
suggest
epitop
could
use
vaccin
develop
addit
result
show
antibodi
recognit
glycoprotein
chang
throughout
cours
diseas
experiment
infect
macaqu
could
due
spatial
posit
bcell
epitop
nativ
form
glycoprotein
complex
differenti
induct
neutral
antibodi
expos
hidden
bcell
epitop
could
contribut
antibodymedi
clearanc
entir
cours
diseas
import
chikv
vaccinolog
sinc
underscor
import
elicit
broad
antibodi
respons
target
expos
hidden
bcell
epitop
would
suffici
cover
import
antigen
viru
neutral
establish
patient
antibodi
singapor
cohort
stronger
bind
capac
chikv
isol
imt
isol
due
differ
epitop
sequenc
two
isol
influenc
epitopeantibodi
bind
capac
demonstr
phenomenon
nonhuman
primat
model
infect
macaqu
isol
encod
k
glycoprotein
strongli
induc
antichikv
antibodi
particular
linear
bcell
epitop
amino
acid
dpi
line
observ
significantli
stronger
neutral
activ
imt
isol
encod
k
compar
isol
encod
q
figur
data
complement
separ
studi
show
stronger
neutral
antibodi
respons
anim
infect
ecsa
strain
compar
anim
infect
west
african
strain
paradox
differ
neutral
capac
observ
lost
macaqu
sera
taken
dpi
incident
sera
taken
time
point
also
rel
low
level
antichikv
antibodi
bcell
epitop
amino
acid
observ
highlight
import
incorpor
variou
compon
antigen
prepar
chikv
vaccin
develop
epitop
sequenc
cover
relev
isol
variou
geograph
region
favor
order
offer
complet
coverag
chikv
infect
global
four
common
linear
bcell
epitop
glycoprotein
could
identifi
antibodi
obtain
patient
chikvinfect
mice
two
epitop
common
patient
chikvinfect
macaqu
tabl
underlin
sequenc
recent
studi
also
demonstr
chikvinfect
patient
react
seroposit
glycoprotein
observ
support
studi
bcell
epitop
identifi
along
glycoprotein
mous
human
monoclon
antibodi
contrastingli
linear
epitop
along
glycoprotein
detect
antibodi
chikvinfect
mice
compar
antibodi
obtain
experimentallyinfect
mous
model
alphavirus
also
identifi
epitop
glycoprotein
diverg
epitop
recognit
variou
anim
model
suggest
exist
speciesrel
differ
humor
respons
upon
viru
infect
vaccin
candid
chikv
test
macaqu
studi
assess
mous
model
model
protect
effect
close
associ
gener
neutral
antibodi
report
exact
epitop
involv
previou
work
chikvinfect
macaqu
show
natur
infect
led
viral
persist
macaqu
test
dpi
despit
robust
innat
immun
respons
protect
vitro
comprehens
studi
exact
target
infectionversu
vaccinationinduc
antibodi
provid
inform
antibodymedi
protect
chronic
chikv
infect
observ
macaqu
figur
pdf
